IRIS PubliCatt

Zocco, Maria Assunta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.475
NA - Nord America 4.070
AS - Asia 1.244
AF - Africa 59
OC - Oceania 50
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 20
Totale 10.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.023
DE - Germania 2.315
SE - Svezia 1.030
IT - Italia 670
CN - Cina 613
UA - Ucraina 375
IE - Irlanda 241
FR - Francia 215
SG - Singapore 215
GB - Regno Unito 209
IN - India 126
FI - Finlandia 119
RU - Federazione Russa 101
TR - Turchia 88
AU - Australia 47
BE - Belgio 44
CA - Canada 41
PL - Polonia 39
IR - Iran 34
CH - Svizzera 25
HK - Hong Kong 23
SA - Arabia Saudita 21
JP - Giappone 18
CI - Costa d'Avorio 17
NL - Olanda 17
EU - Europa 16
RO - Romania 16
CZ - Repubblica Ceca 14
PH - Filippine 13
IL - Israele 12
TW - Taiwan 12
PK - Pakistan 11
BR - Brasile 10
MY - Malesia 10
CL - Cile 8
EG - Egitto 8
VN - Vietnam 8
ES - Italia 7
GR - Grecia 7
KR - Corea 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
SD - Sudan 6
ZA - Sudafrica 5
AT - Austria 4
ML - Mali 4
TH - Thailandia 4
A1 - Anonimo 3
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
CM - Camerun 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
IQ - Iraq 2
KE - Kenya 2
LT - Lituania 2
MD - Moldavia 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CY - Cipro 1
GL - Groenlandia 1
ID - Indonesia 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MX - Messico 1
PR - Porto Rico 1
TT - Trinidad e Tobago 1
Totale 10.939
Salva come PNG Salva come JPEG
Città #
Chandler 910
Ashburn 315
Dublin 238
Jacksonville 190
San Mateo 190
New York 187
Ann Arbor 167
Nürnberg 157
Rome 148
Singapore 137
Nanjing 125
Cattolica 120
Marseille 113
Wilmington 107
Chicago 102
Boston 89
Beijing 84
Milan 83
Woodbridge 79
Izmir 78
Munich 77
Moscow 73
Princeton 73
Dearborn 68
Bremen 64
Seattle 61
Boardman 60
Helsinki 45
Nanchang 45
Los Angeles 43
Houston 40
Redwood City 39
Brussels 38
Hangzhou 36
Fairfield 35
Zhengzhou 34
Tianjin 29
Hebei 28
Lawrence 28
Kraków 27
Lancaster 26
Norwalk 25
Pune 24
University Park 24
Augusta 23
Leawood 22
Mountain View 21
Shenyang 20
Fremont 19
Changsha 18
Abidjan 17
Guangzhou 17
Jiaxing 17
Hong Kong 16
Kunming 14
Zurich 14
Shanghai 12
Dammam 11
London 11
Kish 10
Québec 10
Simi Valley 10
Taipei 10
Andover 9
Detroit 9
Sydney 9
Toronto 9
Warsaw 9
Campagna 8
Nuremberg 8
Oggiono 8
San Jose 8
Al Qatif 7
Amsterdam 7
Boydton 7
Brno 7
Edinburgh 7
Jinan 7
Las Vegas 7
Ningbo 7
Provo 7
Redmond 7
Washington 7
Bern 6
Botosani 6
Naples 6
Paris 6
Tokyo 6
Cambridge 5
Changchun 5
Düsseldorf 5
Esslingen am Neckar 5
Indiana 5
Istanbul 5
Khartoum 5
Lahore 5
Lanzhou 5
Lappeenranta 5
Nardò 5
San Francisco 5
Totale 5.197
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 425
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 276
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 273
13C-methionine breath tests for mitochondrial liver function assessment. 201
13C-breath tests in the study of microsomal liver function 191
The role of small intestinal bacterial overgrowth in Parkinson's disease 178
-High prevalence of celiac disease in patients with lactose intolerance 170
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 169
-Hepatic steatosis and vascular disease 166
-Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure 163
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 153
134C-breath tests in the study of mitochondrial liver function 148
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 143
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 142
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 141
13C-breath tests in the study of microsomial liver function 136
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 131
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 128
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 126
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 125
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 124
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 123
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 123
13C-methionine breath tests for mitochondrial liver function assessment 122
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 121
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 120
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 119
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 118
Treatment of H. pylori infection: a review. 118
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 116
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 115
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. 113
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 113
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 111
13C-breath tests in the study of mitochondrial liver function 110
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 110
Diagnosis of bowel diseases: the role of imaging and ultrasonography 110
-Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis 109
-The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure 105
Levofloxacin based regimens for the eradication of Helicobacter pylori 104
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 104
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 100
-Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis 100
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 98
Transdifferentiation of stem cells in pancreatic cells: state of the art 97
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 97
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 94
-From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? 91
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 91
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 91
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis 88
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 87
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 87
Liver transplantation in patients with alcoholic liver disease: A retrospective study 87
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication 85
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication 83
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 82
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. 81
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use 81
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 81
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 80
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 78
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 78
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 77
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 76
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 76
Review article: breath testing for human liver function assessment. 73
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 72
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 72
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 72
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 72
Functional and metabolic disorders in celiac disease: new implications for nutritional treatment 71
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 67
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 65
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 65
Residual respiratory impairment after COVID-19 pneumonia 65
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 64
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 64
Clinical use of albumin in hepatology. 61
A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis 60
Madelung's disease and acute alcoholic hepatitis: case report and review of literature 60
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 59
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 58
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 57
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 57
-Helicobacter pylori and extragastric diseases--other Helicobacters 55
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 55
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 55
Idiopathic chronic constipation: pathophysiology, diagnosis and treatment 54
Probiotics and small bowel mucosa: Molecular aspects of their interactions 54
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 54
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 52
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 51
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 50
The role of elastography in non-Alcoholic fatty liver disease 49
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 48
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation 43
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications 41
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The ‘Gemelli USCP score’ 40
Totale 10.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020983 0 0 79 52 110 96 144 58 92 111 154 87
2020/20211.136 89 86 35 82 117 61 101 31 128 182 196 28
2021/20221.176 86 97 36 95 94 35 25 190 34 64 185 235
2022/20233.146 349 349 254 523 270 398 187 215 309 122 121 49
2023/20241.533 79 356 60 44 66 262 89 48 30 118 168 213
2024/2025148 68 80 0 0 0 0 0 0 0 0 0 0
Totale 11.086